FlaA was recently found to be associated with flagellar filaments of Borrelia burgdorferi. We tested whether antibodies to this protein are a good indicator of infection, as antibodies to FlaA proteins in other spirochetal infections show an increase in titer. Although overproduction of intact FlaA was highly toxic to Escherichia coli, truncated proteins which lacked the N-terminal signal sequence could be successfully overexpressed. Immunoblotting with sera from mammalian hosts infected with B. burgdorferi indicated that FlaA is not an immunodominant antigen in Lyme disease. However, sera from two patients reacted with both recombinant and native FlaA protein, suggesting that B. burgdorferi FlaA was antigenic and expressed in vivo.
Lyme disease, caused by Borrelia burgdorferi, is one of the major vectorborne infectious diseases in the United States (7) . Like other spirochete species, B. burgdorferi has a unique morphological appearance (9, 18) . One striking feature of spirochetes is that they all contain periplasmic flagella (PFs) which are located between the outer membrane sheath and the cell cylinder. The PFs differ from the flagella of other bacteria, as they are composed of two classes of proteins. The flagellar outer sheath protein is composed of FlaA, and the flagellar core is made up of FlaB (5, 6, 9, 23-26, 29, 34, 42, 43) . FlaB shows homology to flagellar proteins of other bacteria, whereas FlaA is unique (21, 34, 43) . FlaA and FlaB proteins have been shown to have both antigenic and sequence similarity among several different spirochete species.
FlaA and FlaB of spirochetes trigger strong antibody responses in infected hosts (1, 3, 8, 11, 19, 33, 35, 36, 40, 41) . Accordingly, extensive studies have been carried out to analyze the serological response to these proteins. In fact, antibodies to flagellin have been routinely used in the diagnosis of both Lyme disease and syphilis (22, 30, 32, 35, 36) . Anti-FlaB is usually the first detectable antibody found in the acute stage of Lyme disease and is consistently present during the entire infection (1, 11, 30, 32, 40, 41) . Although these antibodies do not provide protection from infection and disease progression (13, 20) , FlaB antibody has been suggested to be involved in the immunopathology of chronic Lyme disease (40) . With respect to syphilis, the presence of antibodies to purified flagellin from the related spirochete Treponema phagedenis has been extensively used to diagnose Treponema pallidum infection (35, 36) . In addition, anti-FlaA antibody production has been evaluated for use in the diagnosis of swine dysentery caused by Serpulina hyodysenteriae (24, 28) .
The PFs of B. burgdorferi were previously thought to differ from those of other spirochetes: only one 41.0-kDa FlaB protein species was found associated with its PFs (4, 9, 10, 14, 27) . However, our recent genetic and biochemical results indicated that the PFs of B. burgdorferi consist of at least two proteins of 41.0-kDa (FlaB) and 38.0-kDa (FlaA) (15, 16) . In the present study, we examined whether B. burgdorferi FlaA protein is an immunodominant antigen in various infected mammalian hosts. In addition, by constructing truncated FlaA proteins, we also localized the portion of B. burgdorferi FlaA that is antigenically similar to its counterpart in T. pallidum.
Cloning flaA into the expression vectors. Because overexpression of intact FlaA of T. pallidum has been shown to be toxic to Escherichia coli (21), we expected that overexpression of B. burgdorferi FlaA would be difficult. Accordingly, we engineered several recombinant flaA constructs and tested their expression in different expression systems, including pPROEX-1, pMAL-p2, pGXT-2T, and pET-23a ( Table 1 ). The pGXT-2T vector was modified to pGXT-21 by inserting a BamHI site in front of the HindIII site. In order to clone flaA, the appropriate pairs of primers containing artificial restriction sites were used to amplify this gene by PCR from the chromosome of B. burgdorferi 212. The PCR products were inserted into the expression vectors at the following sites: NdeI-HindIII for pPROEX-1, EcoRI-HindIII for pMAL-p2, and BamHI-HindIII for pGXT-21 and pET-23a ( Table 2 ). E. coli BL21(DE3) plysE (Novagen) was used to express flaA and its derivatives under the T7 promoter (pET-23a). E. coli DH5Ј␣ (Gibco-BRL) was utilized in the cloning and expression of the other recombinant FlaA proteins. The conditions for the expression of the recombinant proteins were based on the suppliers' instructions or were previously described (17) . The overexpressed proteins were purified by affinity chromatography according to the manufac- (Table 2) . One unusual phenomenon most likely related to the toxicity of FlaA was observed. In cloning the gene into two of the vectors, the same 1-bp deletion occurred immediately after the signal sequence (pET-FlaA and pGST-FlaA; Fig. 1 ). This deletion results in an open reading frame shift that should lead to early translational termination. It most likely occurred during cloning and selection in E. coli rather than during PCR amplification, as sequencing PCR products directly revealed no mutation. On the other hand, no mutations were detected in clones containing pPro-FlaA and pMBP-FlaA. Expression of these fusion proteins was extremely toxic to the host cells. After adding 1 mM IPTG (isopropyl-␤-D-thiogalactopyranoside) for induction, the cells stopped growing and the culture dramatically decreased in cell density within 2 h. These results indicate that, as shown with FlaA of other spirochetes (21) , the expression of B. burgdorferi FlaA is detrimental to E. coli.
We also determined if truncated FlaA that lacked the signal sequence (amino acids 1 to 26) could be successfully expressed in E. coli. We found that the expression of pMBP-FlaAd1 still inhibited cell growth. This vector contains a signal sequence, and the truncated protein should be excreted into the periplasmic space. For unknown reasons, the truncated proteins from both pET-FlaAd1 and pGST-FlaAd1 were not expressed, although sequence analysis indicated that there were no mutations in the cloned genes. On the other hand, the truncated FlaA protein from pPro-FlaAd1 that had a deleted N-terminal sequence (amino acids 1 to 26) was successfully expressed in E. coli (Table 2 and Fig. 2a, lane 8) . After further deletion of FlaA (amino acids 1 to 76), we had no difficulty expressing the truncated proteins from plasmids pMBP-FlaAd2 and pGSTFlaAd2 (Table 2 and Fig. 2a) . These results suggest that overproduced FlaA proteins had an adverse effect on the E. coli cells and that the N terminus of B. burgdorferi FlaA is necessary for this toxicity.
Strong reactivity of the recombinant FlaA protein with anti-T. pallidum FlaA antibody. We have previously shown by Western blot analysis that the anti-T. pallidum FlaA antiserum reacted strongly and specifically with a 38.0-kDa B. burgdorferi FlaA protein (16) . We performed immunoblots with this antiserum in order to examine the reactivity of each of the purified recombinant FlaA proteins (pPro-FlaAd1, pMBP-FlaAd2, and pGST-FlaAd2; Fig. 2a, lanes 3, 6, and 9 ). As shown in Fig. 2b , all three recombinant FlaA proteins reacted with this antiserum. These findings support our previous contention that anti-T. pallidum FlaA reacts with a corresponding homolog from B. burgdorferi and that this protein is encoded by the flaA gene (16) . The strongest Western blot reactions were found with both pPro-FlaAd1 and purified PFs (Fig. 2b, lanes 3 and  4) . The PFs were isolated by a mechanical shearing method (15, 27) . Evidently, a strong B-cell epitope exists near the N terminus of FlaA between amino acids 26 and 76, since a deletion of this region (Fig. 2b, lanes 1 and 2) results in a marked decrease in reactivity.
FlaA is not an immunodominant antigen in Lyme disease. In other spirochetal species, FlaA is a major antigen and antiFlaA antibody can be readily detected in the serum of infected hosts (28, 34) . We questioned whether this was also true with b The sequence of the cloned gene was compared with results obtained by direct sequencing of PCR products. The site for one nucleotide deletion is illustrated in Fig. 1 .
c Plasmid inhibited the growth of the host cells. d All pMBP constructs contain a peptide signal sequence for secretion.
respect to B. burgdorferi; i.e., is FlaA a major immunogen during infection? To answer this question, we tested serum samples from different mammalian species that had been infected with B. burgdorferi. The sera and sources were as follows: sera from a white mouse (tick bite infection without clinical symptoms) and rabbits (tick bite infection or intravenous injection infection), provided by T. Schwan (Rocky Mountain Laboratories, Hamilton, Mont.); sera from a preinfected and postinfected rhesus monkey with arthritis (tick bite infection), provided by M. T. Philipp (Tulane University, New Orleans, La.) (37); and 14 serum specimens from healthy humans and 19 serum specimens from Lyme disease patients, provided by R. C. Johnson (University of Minnesota, Minneapolis), M. V. Assous (Faculté de Médecine, Cochin-Port Royal, Paris, France), and West Virginia University (1). The human sera were positive based on enzyme-linked immunosorbent assay positivity with confirmation by Western blotting. A highly sensitive enhanced chemiluminescence system (Amersham) was utilized in Western blot analysis (12, 16, 39) . Second antibodies directed to immunoglobulins from mice, rabbits, and humans were obtained either from Amersham or Southern Biotechnology Associates Inc. The sera were usually diluted from 1:1,000 to 1:6,000. Lower dilutions resulted in nonspecific high background reactivities. We used recombinant pProFlaAd1 as the test antigen, as this protein showed the highest immunoreactivity (Fig. 2b) . We also tested antibody to the native antigen, as described below.
As shown in Table 3 , all sera from infected animals, along with sera from 19 infected humans, reacted strongly with the native 41-kDa FlaB protein, which was purified by separation by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) followed by electroelution (2). All sera from infected animals and patients also reacted with several other proteins besides FlaB (not shown). Sera from the 14 noninfected humans were negative, as was that from the preinfected rhesus monkey (not shown). These results are consistent with previous reports that FlaB is an immunodominant antigen in infected animals and humans (31, 40) . In order to compare the antigenicity of native FlaA with that of recombinant FlaA, we employed two controls in the immunoblotting analysis: one was an HB19Fla
Ϫ mutant, while the other was a crude PF fraction (15) . Use of these two controls enabled us to identify antibodies to the native FlaA protein. HB19Fla
Ϫ fails to synthesize both FlaA and FlaB (15, 38) . Therefore, this mutant served as a negative control and the PF fraction served a positive control. In contrast to that found for FlaB, the sera from B. burgdorferi-infected animals did not contain anti-FlaA antibody. Positive reactions with FlaA were found for only two Lyme disease patients ( Table 3 ). The serum from one patient gave stronger reactions than the other, but both reacted to recombinant FlaA and native FlaA, along with FlaB (Fig. 3) . The bands corresponding to both FlaA and FlaB proteins were missing in the control HB19Fla Ϫ , indicating that the 41-and 38-kDa proteins identified by this serum truly represent FlaB and FlaA, respectively. None of the sera tested reacted with only native FlaA and not recombinant FlaA. Although FlaA is not a major antigen for B. burgdorferi, these findings suggest that FlaA is indeed expressed in vivo and that it elicited a specific antibody response in the infected host.
The data we have obtained are in contrast with observations made with other pathogenic spirochetes (28, 34) . B. burgdorferi FlaA does not appear to be a consistent immunodominant antigen in infected mammalian hosts. One possible explanation is that, unlike other spirochetes in which FlaA is the major filament component and is expressed at a relatively high level, only relatively small amounts of FlaA are present in B. burgdorferi (15) . Therefore, although FlaA is a protein unique to spirochetes, our results suggest that it is not a good candidate for the serodiagnosis of Lyme disease. 
